Genmab — Maj 2018
-
-
-
Nevertheless I am much more confident now than before, given the fact that Janssen is expanding the whole study. They wouldn't expand a dead cat. Smells bad. This expansion is almost as good as a read out. Surely we cannot know how good data are, but they are good enough to a continuation.
-
-
Mon ikke det bare er shorterne der har solgt en portion på GMXAY for at skabe panik. De er jo i klemme med mange shorts og man kunne godt forestille sig de har købt en portuion på GMXAY tidligere som de nu sælger for at banke kursen ned. Det kan næsten kun være en investor der står for den store omsætning
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind